When Arglaes film dressing featuring controlled release antimicrobial silver was first introduced in the United States a few years ago, physicians at prominent medical facilities, such as New York University Medical Center and Cleveland Clinic Heart Center, called it a significant development in the battle against infection. The recently launched Arglaes Powder has even greater application in helping to fight antibiotic-resistant bacteria, especially in deep, hard-to-treat wounds. Arglaes has no known resistance, it has no known major side effects, and it maintains an effective antimicrobial barrier for up to five days.
       Since it is in a powder form, Arglaes Powder delivers controlled-release antimicrobial silver to any size, shape, or depth of wound. Utilizing controlled-release polymers, Arglaes Powder delivers a constant stream of silver ions into the wound. This technology creates a barrier environment hostile to most known bacteria and fungi but remains completely safe to healthy cells.
       In addition, Arglaes Powder contains alginate to aid in fluid handling. As the powder mixes with wound exudate, it turns into a gel that adheres to the wound bed and is easily removed during wound irrigation.
       Arglaes Powder is ideal for use on difficult-to-dress exudating wounds where a traditional dressing may be difficult to apply. Wound types that benefit from Arglaes Powder include pressure ulcers, arterial ulcers, venous ulcers, diabetic ulcers, donor sites, dermal lesions, trauma injuries, incisions, and minor burns.
       Arglaes is exclusively distributed in the United States by Medline Industries, Inc. For more information, call (800) Medline.